Conventional histopathologic evaluation of bladder cancer, encompassing tumor grade and stage, is inadequate to accurately predict the behavior of most bladder tumors. Intense research efforts are under way to identify and
Roger Dreicer, MD
Advertisement
Articles by Roger Dreicer, MD
Advertisement
Latest Updated Articles
- Molecular Markers for Diagnosis, Staging, and Prognosis of Bladder Cancer
Published: November 1st 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
2
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
3
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
4
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
5
